{"entity":{"type":"insider","cik":"0001837741","url":"/insider/0001837741","json_url":"/insider/0001837741.json","name":"Mano Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2023-03-02","last":"2026-05-15","span_basis":"filed_date"},"name_variants":[{"name":"Mano Michael","source":"filing","n_filings":8,"first_seen":"2023-03-02","last_seen":"2026-05-15"}],"transactions":[{"id":5983306,"accession":"0001193125-26-226604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-226604","line_url":"/filing/0001193125-26-226604#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (EVP, CLO&Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CLO&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CLO&Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":266.0,"shares_display":"266","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":2527.0,"total_display":"2,527.00","total_whole":"2,527","shares_owned_after":94398.0,"shares_owned_after_display":"94,398","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-14","filed_date":"2026-05-15","scope":"insider"},{"id":5950566,"accession":"0001837741-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001837741-26-000003","line_url":"/filing/0001837741-26-000003#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (EVP, CLO&Secretary)","role_mark":"O","role_mark_label":"Officer (EVP, CLO&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CLO&Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3526.0,"shares_display":"3,526","price_per_share":9.4095,"price_display":"9.41","price_state":"stated","total_value":33177.897,"total_display":"33,177.90","total_whole":"33,178","shares_owned_after":93964.0,"shares_owned_after_display":"93,964","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5069180,"accession":"0001193125-25-205049","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-205049","line_url":"/filing/0001193125-25-205049#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (SVP, General Counsel&Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel&Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":234.0,"shares_display":"234","price_per_share":6.43,"price_display":"6.43","price_state":"stated","total_value":1504.62,"total_display":"1,504.62","total_whole":"1,505","shares_owned_after":21425.0,"shares_owned_after_display":"21,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-09-15","filed_date":"2025-09-16","scope":"insider"},{"id":4981119,"accession":"0000950170-25-034650","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-034650","line_url":"/filing/0000950170-25-034650#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (SVP, General Counsel&Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel&Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2793.0,"shares_display":"2,793","price_per_share":6.29,"price_display":"6.29","price_state":"stated","total_value":17567.97,"total_display":"17,567.97","total_whole":"17,568","shares_owned_after":21047.0,"shares_owned_after_display":"21,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-06","scope":"insider"},{"id":2986504,"accession":"0000950170-24-104038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-104038","line_url":"/filing/0000950170-24-104038#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (SVP, General Counsel&Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel&Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3971.0,"shares_display":"3,971","price_per_share":0.7218,"price_display":"0.72","price_state":"stated","total_value":2866.2678,"total_display":"2,866.27","total_whole":"2,866","shares_owned_after":273881.0,"shares_owned_after_display":"273,881","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-04","filed_date":"2024-09-05","scope":"insider"},{"id":2175895,"accession":"0000950170-24-025190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-025190","line_url":"/filing/0000950170-24-025190#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (SVP, General Counsel&Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel&Secretary","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3576.0,"shares_display":"3,576","price_per_share":1.2,"price_display":"1.20","price_state":"stated","total_value":4291.2,"total_display":"4,291.20","total_whole":"4,291","shares_owned_after":277852.0,"shares_owned_after_display":"277,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider"},{"id":2175891,"accession":"0000950170-24-025190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-025190","line_url":"/filing/0000950170-24-025190#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (SVP, General Counsel&Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel&Secretary","security_title":"Common","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16973.0,"shares_display":"16,973","price_per_share":1.17,"price_display":"1.17","price_state":"stated","total_value":19858.41,"total_display":"19,858.41","total_whole":"19,858","shares_owned_after":281428.0,"shares_owned_after_display":"281,428","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-29","filed_date":"2024-03-04","scope":"insider"},{"id":8116635,"accession":"0001209191-23-048161","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048161","line_url":"/filing/0001209191-23-048161#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (SVP, General Counsel&Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel&Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3888.0,"shares_display":"3,888","price_per_share":1.3313,"price_display":"1.33","price_state":"stated","total_value":5176.0944,"total_display":"5,176.09","total_whole":"5,176","shares_owned_after":142234.0,"shares_owned_after_display":"142,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":7831207,"accession":"0001209191-23-014865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-014865","line_url":"/filing/0001209191-23-014865#line-2","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001837741","owner_name":"Mano Michael","owner_display_name":"Mano Michael","owner_url":"/insider/0001837741","role":"Officer (SVP, General Counsel&Secretary)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel&Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel&Secretary","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6878.0,"shares_display":"6,878","price_per_share":3.0292,"price_display":"3.03","price_state":"stated","total_value":20834.8376,"total_display":"20,834.84","total_whole":"20,835","shares_owned_after":146122.0,"shares_owned_after_display":"146,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (EVP, CLO&Secretary)","n_filings":8,"first_seen":"2023-03-02","last_seen":"2026-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001837741","retrieved_at":"2026-08-24T21:32:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}